Skip to main content
. 2018 Mar 6;84(5):972–986. doi: 10.1111/bcp.13533

Table 2.

Summary of input parameters used for repaglinide simulations

Simcyp default CYP3A4–CYP2C8 correlation Comments
Molecular weight (g mol −1 ) 452.6 452.6
log P 3.98 3.98
Compound type Ampholyte Ampholyte
pK a 4.2, 6.0 4.2, 6.0
Blood/plasma ratio 0.62 0.62
Fraction unbound in plasma 0.023 0.023
Absorption
Model First‐order First‐order
Fraction absorbed 0.98 0.98
Absorption rate constant (l h −1 ) 1.6 1.6
Fraction of drug unbound in enterocyte 1 1
Caco‐2 permeability (×10 −6 cm s −1 ) 24.1 24.1
Predicted P eff,man (×10 −4 cm s −1 ) 3.89 3.89
Distribution
Model Full PBPK Full PBPK
V ss (l kg −1 ) 0.24 0.24
K p scalar 3.3 3.3
Elimination
HLM, CYP2C8 K m (μM) 2.3 Transferred to parameter for recombinant
HLM, CYP2C8 V max (pmol min −1 mg −1 ) 300.8 Transferred to parameter for recombinant
HLM, CYP3A4 K m (μM) 13.2 Transferred to parameter for recombinant
HLM, CYP3A4 V max (pmol min −1 mg −1 ) 958.2 Transferred to parameter for recombinant
Recombinant, CYP3A4 K m (μM) 13.2 CYP3A4 Km in HLM
Recombinant, CYP3A4 V max (pmol min −1 mg −1 ) 6.99 Calculated from CYP3A4 Vmax in HLM
Recombinant, CYP3A5 K m (μM) 2.3 CYP2C8 Km in HLM
Recombinant, CYP3A5 V max (pmol min −1 mg −1 ) 12.53 Calculated from CYP2C8 Vmax in HLM
CL R (l h −1 ) 0.013 0.013
Hepatic transport
OATP1B1 CL int,T (μL min −1 million cells −1 ) 246 246
CL PD (ml min −1 million hepatocytes −1 ) 0.089 0.089

CLint, T, transporter‐mediated intrinsic clearance; CLPD, passive diffusion clearance; CLR, renal clearance; Full PBPK model, full physiologically‐based pharmacokinetic model; HLM, human liver microsomes; Km, Michaelis–Menten constant; Kp, tissue to plasma partition coefficient; Peff,man, human jejunum permeability; Vmax, maximum rate of metabolism; Vss, volume of distribution at steady state